A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Mitapivat in Subjects With Sickle Cell Disease
2022-11-22
عنوان الدراسة
A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Mitapivat in Subjects With Sickle Cell Disease
داعم الدراسة
Agios Pharmaceuticals, Inc.
دواء الدراسة
Mitapivat
رقم بروتوكول الدراسة
AG348-C-020
حالة الدراسة
Ongoing
موقع الدراسة
King Khalid University Hospital (Riyadh)
مرحلة الدراسة
2/3
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。